FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914003173> ?p ?o ?g. }

• W2914003173 endingPage "944" @default.
• W2914003173 startingPage "933" @default.
• W2914003173 abstract "The goals of this study were to determine the effects of combined inhibition of STAT3 and vascular endothelial growth factor receptor 2 (VEGFR2) pathways on the radiosensitivity of non-small-cell lung cancer (NSCLC) cells, and to assess the underlying mechanisms.The expressions of VEGFR2, STAT3, related signaling molecules, hypoxia-inducible factor 1-alpha (HIF-1α), and cyclin D1 were determined by Western blotting. Radiosensitivity was assessed using the colony-forming assay, and cell cycle and cell death were analyzed by flow cytometry. A nude mouse xenograft tumor model of Calu-1 cells was established. The hepatorenal toxicity of the above-mentioned treatment on tumor-bearing mice was observed by H&E staining. The expression of STAT3, VEGFR2, HIF-1α, and cyclin D1 of the transplanted tumor tissues was detected by immunohistochemistry. Apoptosis of tumor tissues was evaluated by TUNEL staining.In vitro, we selected two cell lines with high expression levels of STAT3, including Calu-1 cells that exhibit high VEGFR2 expression and A549 cells that exhibit low VEGFR2 expression. When apatinib treatment was combined with S3I-201, the expression of VEGFR2, STAT3, and their downstream signaling molecules was significantly decreased (P<0.01). There was an increase in cell death and G2/M phase arrest after treatments, with the most significant changes occurring upon dual inhibition of STAT3 and VEGFR2 (P<0.01). In vivo, combined treatment of radiotherapy and dual inhibition of VEGFR2 and STAT3 was well tolerated and did not deliver additional toxicity. Compared with the control group and the radiation treatment (RT) + apatinib or RT + S3I-201 duplex group, the expression level of STAT3, p-STAT3, VEGFR2, HIF-1α, and cyclin D1 in the triple group (RT + apatinib + S3I-201) was the lowest, and the proportion of apoptotic cells was the highest (P<0.05).The combined inhibition of VEGFR2 and STAT3 is effective in enhancing radiosensitizing effects in NSCLC cells." @default.
• W2914003173 created "2019-02-21" @default.
• W2914003173 creator A5003105897 @default.
• W2914003173 creator A5003554962 @default.
• W2914003173 creator A5008131882 @default.
• W2914003173 creator A5013604432 @default.
• W2914003173 creator A5048826252 @default.
• W2914003173 creator A5068301710 @default.
• W2914003173 creator A5069498085 @default.
• W2914003173 date "2019-01-01" @default.
• W2914003173 modified "2023-10-12" @default.
• W2914003173 title "<p>Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells</p>" @default.
• W2914003173 cites W1500422623 @default.
• W2914003173 cites W1910905929 @default.
• W2914003173 cites W1967429436 @default.
• W2914003173 cites W1970987838 @default.
• W2914003173 cites W1981404894 @default.
• W2914003173 cites W1986515922 @default.
• W2914003173 cites W2017117774 @default.
• W2914003173 cites W2022052477 @default.
• W2914003173 cites W2031583735 @default.
• W2914003173 cites W2035834369 @default.
• W2914003173 cites W2037841397 @default.
• W2914003173 cites W2047539399 @default.
• W2914003173 cites W2059841606 @default.
• W2914003173 cites W2066047258 @default.
• W2914003173 cites W2066164864 @default.
• W2914003173 cites W2069292400 @default.
• W2914003173 cites W2089334378 @default.
• W2914003173 cites W2092933936 @default.
• W2914003173 cites W2095558691 @default.
• W2914003173 cites W2097072557 @default.
• W2914003173 cites W2102912734 @default.
• W2914003173 cites W2106691187 @default.
• W2914003173 cites W2110019832 @default.
• W2914003173 cites W2117584564 @default.
• W2914003173 cites W2126309017 @default.
• W2914003173 cites W2129579134 @default.
• W2914003173 cites W2130832131 @default.
• W2914003173 cites W2143164105 @default.
• W2914003173 cites W2143354789 @default.
• W2914003173 cites W2151285519 @default.
• W2914003173 cites W2174523789 @default.
• W2914003173 cites W2191562517 @default.
• W2914003173 cites W2221858511 @default.
• W2914003173 cites W2557415498 @default.
• W2914003173 cites W2568352938 @default.
• W2914003173 cites W2804291105 @default.
• W2914003173 doi "https://doi.org/10.2147/ott.s186559" @default.
• W2914003173 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6357889" @default.
• W2914003173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30774379" @default.
• W2914003173 hasPublicationYear "2019" @default.
• W2914003173 type Work @default.
• W2914003173 sameAs 2914003173 @default.
• W2914003173 citedByCount "11" @default.
• W2914003173 countsByYear W29140031732019 @default.
• W2914003173 countsByYear W29140031732020 @default.
• W2914003173 countsByYear W29140031732021 @default.
• W2914003173 countsByYear W29140031732022 @default.
• W2914003173 countsByYear W29140031732023 @default.
• W2914003173 crossrefType "journal-article" @default.
• W2914003173 hasAuthorship W2914003173A5003105897 @default.
• W2914003173 hasAuthorship W2914003173A5003554962 @default.
• W2914003173 hasAuthorship W2914003173A5008131882 @default.
• W2914003173 hasAuthorship W2914003173A5013604432 @default.
• W2914003173 hasAuthorship W2914003173A5048826252 @default.
• W2914003173 hasAuthorship W2914003173A5068301710 @default.
• W2914003173 hasAuthorship W2914003173A5069498085 @default.
• W2914003173 hasBestOaLocation W29140031731 @default.
• W2914003173 hasConcept C126322002 @default.
• W2914003173 hasConcept C190283241 @default.
• W2914003173 hasConcept C196795494 @default.
• W2914003173 hasConcept C199835354 @default.
• W2914003173 hasConcept C206684579 @default.
• W2914003173 hasConcept C2778923194 @default.
• W2914003173 hasConcept C29537977 @default.
• W2914003173 hasConcept C502942594 @default.
• W2914003173 hasConcept C509974204 @default.
• W2914003173 hasConcept C54355233 @default.
• W2914003173 hasConcept C55493867 @default.
• W2914003173 hasConcept C62112901 @default.
• W2914003173 hasConcept C71924100 @default.
• W2914003173 hasConcept C86803240 @default.
• W2914003173 hasConceptScore W2914003173C126322002 @default.
• W2914003173 hasConceptScore W2914003173C190283241 @default.
• W2914003173 hasConceptScore W2914003173C196795494 @default.
• W2914003173 hasConceptScore W2914003173C199835354 @default.
• W2914003173 hasConceptScore W2914003173C206684579 @default.
• W2914003173 hasConceptScore W2914003173C2778923194 @default.
• W2914003173 hasConceptScore W2914003173C29537977 @default.
• W2914003173 hasConceptScore W2914003173C502942594 @default.
• W2914003173 hasConceptScore W2914003173C509974204 @default.
• W2914003173 hasConceptScore W2914003173C54355233 @default.
• W2914003173 hasConceptScore W2914003173C55493867 @default.
• W2914003173 hasConceptScore W2914003173C62112901 @default.
• W2914003173 hasConceptScore W2914003173C71924100 @default.
• W2914003173 hasConceptScore W2914003173C86803240 @default.
• W2914003173 hasLocation W29140031731 @default.

• next